Table 1.
Composition of lipids and drugs used in formulation preparation.
| Formulation | Drug | DOPCE (mg) | Cholesterol (mg) | DSPE-mPEG-2000 (mg) | PBS (mL) |
|---|---|---|---|---|---|
| [R4W4] Liposomes | 400 (μg) | 25 | 7 | 10 | 10 |
| Rifampicin Liposomes | 5 (mg) | 25 | 7 | 10 | 10 |
| Azithromycin Liposomes | 2 (mg) | 25 | 7 | 10 | 10 |
| Peptide-Rifampicin Liposomes | 400 (μg)/5 (mg) | 25 | 7 | 10 | 10 |
| Peptide-Azithromycin Liposomes | 400(μg)/2 (mg) | 25 | 7 | 10 | 10 |
| Blank Liposome | No drug/peptide | 25 | 7 | 10 | 10 |